Main > ONCOLOGY (**) > Breast Cancer>HR+>HER2->MET *** > Treatment > USA. E. Abemaciclib+> **

---

USA. E. Abemaciclib+> **'s subsections
(*) CA Approval Date: 2019. 04.09.
(*) CA Launch Date: 2019. 08.08.
(*) USA Approval Date: 2017. 09.28.
+Fulvestrant
>Progressed>Endocrine Therapy
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2019. 11.26.
TradeMark
TradeMark Web-Site

USA. E. Abemaciclib+> **'s products
This section has no products